Where evidence meets experience .
Reach more participants, generate high-quality data, and simplify clinical trials, with a unified, easy-to-use platform.
One platform, from start to finish.
Onboard your participants
Total Consent Management incorporates easy-to-use tools like TeleVisit, remote scheduling, and compliant wet and dry signature to get your study started quickly and smoothly.
Take control of your trial
Keep your study on track and generate high-quality evidence with robust features like remote data collection, study notifications, participant reminders, and real-time reporting.
Data reporting and visualization
Oversight of your study data at your fingertips.
The Medable Effect
ROI for Phase III trials*
Rated DCT platform
Top Pharma customers
What makes us different
Best-in-class user experience
Informed by DCT experts, patient insights, and site feedback, the Medable platform accommodates the complex research landscape in an intuitive and simple user interface.
Designed to scale
Offered in over 60 countries and 120 languages, our cloud-agnostic, single API platform offers self-service build and a library of system integrations for maximum reach and scalability.
Extensive DCT network
Your study benefits from our extensive network of partners from retail pharmacy and site networks, data providers for RWE and LTFU, and direct-to-patient offering of connected sensors and home health providers.
Trusted by
The latest from Medable
Demo On Demand: eCOA+, patient & site experiences, and pulse oximeter sensor
VP of Solution Consulting, Jess Dolphi, showcases a few of the platform’s features, including site experience, patient experience, data and oversight dashboards, and a demonstration of connecting a pulse oximeter sensor for remote data capture.
U.S. Renal Care achieves 75% site adoption of eConsent with Medable
Medable’s Total Consent, used by U.S. Renal Care in top ten pharma-sponsored study, proved to be a flexible, fast, and efficient solution for the elderly renal care population.
Ethical Review of Decentralized Clinical Trials (DCTs): Tools, Resources & Best Practices
Industry experts from Medable and Harvard School of Medicine discuss how to equip your future digital/decentralized trial IRB & ethics submissions for success.
Medable Wins 2024 Prix Galien UK Award for Best Digital Health Solution
Medable today announced that its evidence generation platform was awarded “Best Digital Health Solution” from a field of 17 nominees at the Prix Galien UK Forum in London. This marks the second time Medable has won the Best Digital Health Solution award, first taking home the honor in 2023 at the Prix Galien US ceremony.
New Research from Partnership for Advancing Clinical Trials (PACT) Reveals Decentralized Clinical Trials (DCTs) Beat Timeline Expectations
Medable today announced that the Partnership for Advancing Clinical Trials (PACT) consortium in conjunction with the Tufts Center for the Study of Drug Development (CSDD) has produced compelling results from a new study.
Medable Achieves 75% eConsent Adoption Across Elderly Patients in Pivotal U.S. Renal Care Clinical Trial
The Phase IV trial, funded by a top-10 global pharmaceutical company, had a narrow recruitment window to enroll patients suffering from Anemia in End Stage Kidney Disease (ESKD) across more than 40 dialysis centers, involving 476 site users.